PureTech lifted by news of Roche deal

20th July 2018 Uncategorised 0

Shares in UK-based clinical-stage biopharm PureTech Health have been given a boost by news that Roche has signed up to advance its exosome platform technology in a deal potentially worth more than $1 billion.

More: PureTech lifted by news of Roche deal
Source: News